semaglutide ibd versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial Ozempic and ulcerative colitis: Possible

By Tess Branstetter, Megan Foster, Abbey Fritzel, et al., Published on 01/01/26

Zaya helps your private practice thrive

Understanding the science behind these dosing differences helps you make informed decisions about your weight loss or diabetes treatment

Patients have reported getting unexpectedly pregnant while taking drugs like Ozempic and Mounjaro.

Retatrutide is a weightloss peptide ready to dispatch all over the UK in a Single Day at Sempica

The growing prevalence of metabolic disease, CKD, and ASCVD have prompted investigation into the role of GLP-1R agonists in mitigating cardiovascular and metabolic risks, particularly within the framework of Cardiovascular-Kidney-Metabolic (CKM) Syndrome, irrespective of diabetic status